Loading...
01/12 06:13
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary reflects a mixed outlook. While the company has strong financial metrics and optimistic guidance, the lack of strategic partnerships and specifics on breakeven points and production timelines raises concerns. The focus on edge applications over data centers and the lack of new strategic investor interest further tempers the outlook. The Q&A revealed no major risks but highlighted uncertainties. Overall, without market cap data, the sentiment is neutral, as positive elements are balanced by uncertainties and lack of immediate catalysts.
Net Revenues $6.4 million for Q2 fiscal 2026, up from $4.6 million in Q2 fiscal 2025 (a 39.1% increase). The growth was driven by strong market momentum for leading SRAM solutions.
Gross Margin 54.8% in Q2 fiscal 2026, compared to 38.6% in Q2 fiscal 2025 (a 16.2 percentage point increase). The improvement was due to a favorable product mix.
Operating Expenses $6.7 million in Q2 fiscal 2026, down from $7.3 million in Q2 fiscal 2025 (an 8.2% decrease). The reduction was attributed to lower research and development expenses.
Research and Development Expenses $3.8 million in Q2 fiscal 2026, down from $4.8 million in Q2 fiscal 2025 (a 20.8% decrease). The decrease was due to changes in stock-based compensation expense and government funding offsets.
Selling, General and Administrative Expenses $3 million in Q2 fiscal 2026, up from $2.6 million in Q2 fiscal 2025 (a 15.4% increase). The increase was not explicitly explained.
Operating Loss $3.2 million in Q2 fiscal 2026, down from $5.6 million in Q2 fiscal 2025 (a 42.9% decrease). The improvement was due to higher revenues and lower operating expenses.
Net Loss $3.2 million or $0.11 per diluted share in Q2 fiscal 2026, down from $5.5 million or $0.21 per diluted share in Q2 fiscal 2025 (a 41.8% decrease). The improvement was due to higher revenues and better cost management.
Stock-Based Compensation Expense $856,000 in Q2 fiscal 2026, up from $663,000 in Q2 fiscal 2025 (a 29.1% increase). The increase was not explicitly explained.
Cash and Cash Equivalents $25.3 million as of September 30, 2025, up from $13.4 million as of March 31, 2025 (an 88.8% increase). The increase was likely due to the $50 million equity financing mentioned earlier.
Working Capital $26.8 million as of September 30, 2025, up from $16.4 million as of March 31, 2025 (a 63.4% increase). The increase was likely due to improved cash reserves and operational performance.
Stockholders' Equity $38.6 million as of September 30, 2025, up from $28.2 million as of March 31, 2025 (a 36.9% increase). The increase was likely due to the equity financing and improved financial performance.
Gemini-II chip: Gemini-II chip offers 8x the memory and 10x the performance of Gemini-I, with superior processing at a fraction of the power. It is being optimized for defense applications like drones and satellites.
Plato chip: Plato chip development is underway, with a tape-out milestone expected in early 2027. It builds on Gemini-II's foundation and targets defense applications with high-performance and low-power capabilities.
Equity financing: Closed a $50 million equity financing to accelerate hardware and software development.
Defense and aerospace market: Engaged in SBIR and POC projects, including a $751,000 extension for radiation testing of Gemini-II for satellite applications.
Software ecosystem: Investing in software tools to support Gemini-II integration into AI and signal processing workflows, particularly for edge and defense applications.
Strategic partnerships: Actively seeking partners for Plato chip development to provide funding, testing, and prototyping support.
Commercialization strategy: Focused on converting proof-of-concept projects into commercial customers and expanding relationships into large production programs.
AI compute innovation: Positioning to lead in specialized AI compute architectures for high-value edge and defense applications.
Regulatory and Compliance Risks: The company operates in sectors like defense and aerospace, which are subject to stringent regulatory requirements. Any failure to meet these standards could delay projects or result in penalties.
Supply Chain and IP Acquisition Risks: The company is acquiring IP for the Plato chip and building hardware and software in parallel. Delays or issues in acquiring IP or supply chain disruptions could impact timelines and increase costs.
Financial Risks: The company reported a net loss of $3.2 million in the second quarter of fiscal 2026, indicating ongoing financial challenges. Additionally, changes in product mix have affected gross margins.
Market Competition: The company faces competition from established players like NVIDIA, which could impact its ability to commercialize products like Gemini-II and Plato effectively.
Execution Risks: The company is simultaneously working on multiple initiatives, including Gemini-II commercialization and Plato development. Any mismanagement or delays could hinder progress and market entry.
Customer and Revenue Concentration Risks: A significant portion of revenue comes from a few customers, such as KYEC and Cadence Design Systems. Any loss of these customers could severely impact financial performance.
Economic and Funding Risks: While the company recently raised $50 million, it remains dependent on strategic partners for funding and technical collaboration, especially for the Plato program. Economic uncertainties could also affect future funding opportunities.
Gemini-II Commercialization: The company is focused on converting proof-of-concept projects into commercial customers and expanding these relationships into large production programs in 2026. Gemini-II is central to the near-term commercialization roadmap, with initial benchmark results expected by year-end 2025 and a fully optimized version available in the first half of 2026. The chip is being optimized for defense applications such as drones, satellites, and military vehicles.
Plato Program Development: The company plans to tape out the Plato chip in early 2027. Over the next year, GSI will engage strategic partners for funding, testing, and prototyping early versions of the chip. These partners will also support the development of software libraries and APIs to ensure scalability across multiple markets, starting with defense. Plato will enhance critical functions like SAR imaging, object recognition, and GPS-denied navigation for military applications.
SBIR and Space Development Agency Contracts: GSI received a $751,000 extension for a Space Development Agency contract, which includes funding for radiation-hardened beam testing of Gemini-II. This testing aims to evaluate the chip's robustness for potential use in satellite and aerospace applications.
Revenue and Gross Margin Outlook: For the third quarter of fiscal 2026, the company expects net revenues in the range of $6.0 million to $6.8 million, with a gross margin of approximately 54% to 56%.
The selected topic was not discussed during the call.
The earnings call summary reflects a mixed outlook. While the company has strong financial metrics and optimistic guidance, the lack of strategic partnerships and specifics on breakeven points and production timelines raises concerns. The focus on edge applications over data centers and the lack of new strategic investor interest further tempers the outlook. The Q&A revealed no major risks but highlighted uncertainties. Overall, without market cap data, the sentiment is neutral, as positive elements are balanced by uncertainties and lack of immediate catalysts.
The earnings call presents mixed signals: strong revenue growth and gross margin improvements are positive, but significant declines in sales to key customers and supply chain issues are concerning. The Q&A section reveals ongoing challenges with supply chain constraints and customer order patterns, which could impact future performance. Although there are advancements in product development and partnerships, the lack of clarity in some management responses raises uncertainties. Given these factors, the stock price is likely to remain stable, resulting in a neutral sentiment.
The earnings call presented mixed signals. Financial performance showed improvements in operating losses and gross margins, but the annual revenue declined. Product development is promising with new chips targeting emerging markets, yet market acceptance remains uncertain. The Q&A revealed management's lack of clarity on market size and strategic alternatives, raising concerns. The absence of a share repurchase plan and the need for new funding sources further add to the uncertainty. Overall, the sentiment is neutral due to balanced positive and negative factors, with no strong catalyst for significant stock movement.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
